192 related articles for article (PubMed ID: 16455109)
1. Flavonoid-drug interactions: effects of flavonoids on ABC transporters.
Morris ME; Zhang S
Life Sci; 2006 Mar; 78(18):2116-30. PubMed ID: 16455109
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.
Alvarez AI; Real R; Pérez M; Mendoza G; Prieto JG; Merino G
J Pharm Sci; 2010 Feb; 99(2):598-617. PubMed ID: 19544374
[TBL] [Abstract][Full Text] [Related]
3. The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.
Li Y; Paxton JW
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):267-85. PubMed ID: 23289831
[TBL] [Abstract][Full Text] [Related]
4. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
Moon YJ; Wang X; Morris ME
Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
[TBL] [Abstract][Full Text] [Related]
6. ABC transporters and isothiocyanates: potential for pharmacokinetic diet-drug interactions.
Telang U; Ji Y; Morris ME
Biopharm Drug Dispos; 2009 Oct; 30(7):335-44. PubMed ID: 19623673
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
[TBL] [Abstract][Full Text] [Related]
8. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
Brand W; Schutte ME; Williamson G; van Zanden JJ; Cnubben NH; Groten JP; van Bladeren PJ; Rietjens IM
Biomed Pharmacother; 2006 Nov; 60(9):508-19. PubMed ID: 16978825
[TBL] [Abstract][Full Text] [Related]
9. Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction.
Fleisher B; Unum J; Shao J; An G
J Pharm Sci; 2015 Jan; 104(1):266-75. PubMed ID: 25418056
[TBL] [Abstract][Full Text] [Related]
10. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein.
Zhang S; Yang X; Coburn RA; Morris ME
Biochem Pharmacol; 2005 Aug; 70(4):627-39. PubMed ID: 15979586
[TBL] [Abstract][Full Text] [Related]
11. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
12. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice.
Zhang S; Wang X; Sagawa K; Morris ME
Drug Metab Dispos; 2005 Mar; 33(3):341-8. PubMed ID: 15608138
[TBL] [Abstract][Full Text] [Related]
14. Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein.
Yu CP; Hsieh YC; Shia CS; Hsu PW; Chen JY; Hou YC; Hsieh YW
J Pharm Sci; 2016 Jan; 105(1):343-9. PubMed ID: 26852865
[TBL] [Abstract][Full Text] [Related]
15. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
Wang X; Morris ME
Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
[TBL] [Abstract][Full Text] [Related]
16. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
Zhang S; Morris ME
J Pharmacol Exp Ther; 2003 Mar; 304(3):1258-67. PubMed ID: 12604704
[TBL] [Abstract][Full Text] [Related]
17. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
[TBL] [Abstract][Full Text] [Related]
18. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
19. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.
Li Y; Revalde JL; Reid G; Paxton JW
Drug Metab Rev; 2010 Nov; 42(4):590-611. PubMed ID: 20433315
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
